Asiri Surgical Hospital PLC (COSE:AMSL.N0000)
Sri Lanka · Delayed Price · Currency is LKR 0.00
0.00 (0.00%)
Price not available due to exchange restrictions
Asiri Surgical Hospital Income Statement
Financials in millions LKR. Fiscal year is April - March.
Millions LKR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| 7,523 | 7,182 | 6,620 | 5,635 | 5,838 | 4,230 | Upgrade | |
Revenue Growth (YoY) | 10.50% | 8.49% | 17.48% | -3.48% | 38.02% | 15.73% | Upgrade |
Cost of Revenue | 4,291 | 4,181 | 3,950 | 3,405 | 3,378 | 2,661 | Upgrade |
Gross Profit | 3,231 | 3,001 | 2,670 | 2,229 | 2,460 | 1,568 | Upgrade |
Selling, General & Admin | 2,035 | 2,376 | 2,236 | 1,274 | 1,042 | 893.14 | Upgrade |
Operating Expenses | 2,035 | 2,376 | 2,236 | 1,274 | 1,042 | 893.14 | Upgrade |
Operating Income | 1,196 | 625.01 | 433.92 | 954.96 | 1,418 | 675.12 | Upgrade |
Interest Expense | -304.43 | -338.39 | -615.62 | -947.73 | -247.04 | -245.53 | Upgrade |
Interest & Investment Income | 406.43 | 559.27 | 767.97 | 1,218 | 247.39 | 246.34 | Upgrade |
Currency Exchange Gain (Loss) | - | 3.9 | 8.22 | 5.17 | -8.01 | 0.94 | Upgrade |
Other Non Operating Income (Expenses) | 36.95 | 43.4 | 43.82 | 30.8 | 53.34 | 31.04 | Upgrade |
EBT Excluding Unusual Items | 1,335 | 893.19 | 638.31 | 1,261 | 1,464 | 707.9 | Upgrade |
Gain (Loss) on Sale of Investments | - | - | - | 0.43 | 7.08 | - | Upgrade |
Gain (Loss) on Sale of Assets | - | -0.01 | -0.02 | -0.44 | -0.67 | 0.86 | Upgrade |
Pretax Income | 1,335 | 893.18 | 638.29 | 1,261 | 1,470 | 708.77 | Upgrade |
Income Tax Expense | 580.65 | 519.46 | 515.28 | 621.37 | 223.6 | -150.9 | Upgrade |
Earnings From Continuing Operations | 754.75 | 373.73 | 123.01 | 640.03 | 1,246 | 859.67 | Upgrade |
Minority Interest in Earnings | -129.75 | -108.06 | -91.46 | -84.91 | -61.62 | -37.51 | Upgrade |
Net Income | 625 | 265.67 | 31.55 | 555.12 | 1,185 | 822.16 | Upgrade |
Net Income to Common | 625 | 265.67 | 31.55 | 555.12 | 1,185 | 822.16 | Upgrade |
Net Income Growth | 0.42% | 742.03% | -94.32% | -53.14% | 44.10% | 89.83% | Upgrade |
Shares Outstanding (Basic) | 529 | 528 | 528 | 528 | 528 | 528 | Upgrade |
Shares Outstanding (Diluted) | 529 | 528 | 528 | 528 | 528 | 528 | Upgrade |
EPS (Basic) | 1.18 | 0.50 | 0.06 | 1.05 | 2.24 | 1.56 | Upgrade |
EPS (Diluted) | 1.18 | 0.50 | 0.06 | 1.05 | 2.24 | 1.56 | Upgrade |
EPS Growth | 0.23% | 742.03% | -94.32% | -53.14% | 44.10% | 89.83% | Upgrade |
Free Cash Flow | 2.88 | -435.07 | 98.98 | 248.36 | 863.27 | 431.56 | Upgrade |
Free Cash Flow Per Share | 0.01 | -0.82 | 0.19 | 0.47 | 1.63 | 0.82 | Upgrade |
Dividend Per Share | - | 0.300 | - | - | 2.100 | 0.850 | Upgrade |
Dividend Growth | - | - | - | - | 147.06% | - | Upgrade |
Gross Margin | 42.95% | 41.79% | 40.33% | 39.56% | 42.13% | 37.08% | Upgrade |
Operating Margin | 15.90% | 8.70% | 6.55% | 16.95% | 24.29% | 15.96% | Upgrade |
Profit Margin | 8.31% | 3.70% | 0.48% | 9.85% | 20.29% | 19.44% | Upgrade |
Free Cash Flow Margin | 0.04% | -6.06% | 1.49% | 4.41% | 14.79% | 10.20% | Upgrade |
EBITDA | 1,591 | 1,015 | 845.31 | 1,298 | 1,736 | 987.38 | Upgrade |
EBITDA Margin | 21.14% | 14.13% | 12.77% | 23.03% | 29.74% | 23.34% | Upgrade |
D&A For EBITDA | 394.05 | 389.79 | 411.39 | 342.75 | 318.43 | 312.26 | Upgrade |
EBIT | 1,196 | 625.01 | 433.92 | 954.96 | 1,418 | 675.12 | Upgrade |
EBIT Margin | 15.90% | 8.70% | 6.55% | 16.95% | 24.29% | 15.96% | Upgrade |
Effective Tax Rate | 43.48% | 58.16% | 80.73% | 49.26% | 15.21% | - | Upgrade |
Advertising Expenses | - | 21.81 | 26.42 | 26.35 | 25.14 | 14.24 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.